MOHEALTH Share Price Target 2040

CAGR-based price projection for MOHEALTH (MOHEALTH) targeting 2040, derived from official NSE exchange closing prices.

Bear Case (6.9% CAGR)
Rs 130
2040 Target
Base Case (17.3% CAGR)
Rs 477
2040 Target
Bull Case (49.0% CAGR)
Rs 13,514
2040 Target

Current Market Snapshot

CMP: Rs 50.81
52W High: Rs 53.06
52W Low: Rs 43.17
1Y CAGR: 37.7%
3Y CAGR: 17.3%

Year-by-Year Price Projection

YearBear CaseBase CaseBull Case
2027 Rs 54 Rs 60 Rs 76
2028 Rs 58 Rs 70 Rs 113
2029 Rs 62 Rs 82 Rs 168
2030 Rs 66 Rs 96 Rs 250
2031 Rs 71 Rs 113 Rs 373
2032 Rs 76 Rs 133 Rs 556
2033 Rs 81 Rs 156 Rs 829
2034 Rs 87 Rs 183 Rs 1,235
2035 Rs 93 Rs 214 Rs 1,840
2036 Rs 99 Rs 252 Rs 2,741
2037 Rs 106 Rs 295 Rs 4,085
2038 Rs 114 Rs 346 Rs 6,087
2039 Rs 122 Rs 406 Rs 9,069
2040 Rs 130 Rs 477 Rs 13,514

Other MOHEALTH Price Targets

2025 2026 2027 2028 2030 2035 2050

Frequently Asked Questions

What is the MOHEALTH share price target for 2040?

Based on historical growth analysis, the MOHEALTH share price target for 2040 ranges from Rs 130 (conservative) to Rs 477 (base case) to Rs 13,514 (optimistic). These projections are based on trailing CAGR and should not be treated as guaranteed outcomes.

What is the current share price of MOHEALTH?

The current market price of MOHEALTH (MOHEALTH) is Rs 50.81. The 52-week high is Rs 53.06 and 52-week low is Rs 43.17.

Is MOHEALTH a good stock to buy for the long term?

Long-term investment decisions depend on individual risk tolerance, financial goals, and portfolio diversification. Examine the company's fundamentals, debt-to-equity ratio, promoter holding, and competitive positioning within its sector. BrokerLens provides data-driven analysis; consult a SEBI-registered financial advisor before investing.

What methodology does BrokerLens use for MOHEALTH price targets?

BrokerLens computes price targets using historical Compound Annual Growth Rate (CAGR) derived from official NSE closing prices. Three scenarios are modeled: Bear (conservative at 6.9% CAGR), Base (17.3% CAGR), and Bull (optimistic at 49.0% CAGR). These are statistical projections, not guaranteed forecasts.

Disclaimer: Share price targets on BrokerLens are statistical CAGR projections based on historical NSE closing prices. They are NOT guaranteed outcomes, investment advice, or analyst recommendations. Past performance does not guarantee future results. Consult a SEBI-registered investment advisor before making investment decisions. Mutual fund and equity investments are subject to market risks.